Managing blood pressure during surgery to improve cognitive function in cancer patients

Effects of Different Intraoperative Blood Pressure Management Strategies on Postoperative Cognitive Function and Adverse Outcomes in Tumor Patients With High Risk Factors for Stroke

Not applicable Interventional Zhejiang Cancer Hospital · NCT06711432

This study is testing if keeping blood pressure at a higher level during surgery can help cancer patients think better and avoid confusion after their operation.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment214 (estimated)
Ages40 Years to 85 Years
SexAll
SponsorZhejiang Cancer Hospital Academic / other
Locations1 site (Hangzhou, Zhejiang)
Trial IDNCT06711432 on ClinicalTrials.gov

What this trial studies

This randomized controlled study investigates the effects of different intraoperative blood pressure management strategies on postoperative cognitive function in cancer patients at high risk for stroke. Participants are divided into two groups: one receiving strict blood pressure management to maintain a mean arterial pressure (MAP) of at least 85 mmHg, and the other following conventional management with a MAP of at least 65 mmHg. The study aims to reduce the incidence of delirium and cognitive impairment, as well as serious complications related to blood pressure fluctuations within 30 days post-surgery. A total of 424 subjects are included to ensure robust statistical power.

Who should consider this trial

Good fit: Ideal candidates are cancer patients with multiple risk factors for stroke who are scheduled for abdominal surgeries lasting over two hours.

Not a fit: Patients with severe heart disease, recent strokes, or those requiring emergency surgery may not benefit from this study.

Why it matters

Potential benefit: If successful, this approach could significantly reduce cognitive impairment and serious complications in high-risk cancer patients undergoing surgery.

How similar studies have performed: While similar approaches have been explored, this specific strategy of blood pressure management in high-risk cancer patients is novel.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Patients with high-risk stroke (combined with 3 risk factors or more according to the stroke risk screening table)
2. Patients who plan to undergo surgery for abdominal tumors (gynecological, urinary, hepatobiliary, and gastrointestinal tumors) under general anesthesia are expected to have surgery duration \>2 hours
3. The ASA is rated as Class II or III
4. Patients who underwent invasive arterial blood pressure monitoring before surgery signed informed consent

Exclusion Criteria:

1. Patients do not want to participate in the study
2. Patients with severe heart disease (severe valvular disease, sick sinus syndrome, high atrioventricular block without pacemaker implantation), grade III or above Liver function impairment (Child-Pugh class C)
3. Need kidney replacement therapy; New stroke \<3 months
4. Emergency surgery
5. Preoperative history of mental illness, epilepsy, Parkinson's disease, or myasthenia gravis
6. Speech, vision, or hearing impairment that prevents completion of a cognitive function assessment
7. Situations where strict blood pressure management is not appropriate, such as controlled hypotension during surgery.

Where this trial is running

Hangzhou, Zhejiang

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions TumorStrokeblood pressure management strategiespostoperative cognitive functiontumor patientshigh risk factors for stroke
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.